A phase 3 trial found daraxonrasib extended survival in advanced pancreatic cancer. The results have raised cautious hope, ...
PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...
A new pancreatic cancer drug being tested by doctors in Phoenix is showing promise, potentially doubling survival rates for ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even ...
Most people don’t find out they have pancreatic cancer until the cancer has already gone somewhere it shouldn’t be. There are ...